88.34
price down icon0.58%   -0.2873
 
loading

Gilead Sciences Inc (GILD) Stock Split History

Gilead Sciences Inc has split its stock 5 times since its initial public offering (IPO). The first stock split occurred on February 22, 2001 with the ratio of 2-for-1, meaning that for 1 share of GILD owned pre-split, shareholders then owned 2 shares. 4 more splits have been implemented since then. The most recent stock split took place on January 28, 2013 on a 2-for-1 basis.

These splits have increased GILD stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Gilead Sciences Inc's total market capitalization.

For more detailed information of Gilead Sciences Inc's stock splits, view the table below:

GILD stock split list

Date Split Ratio
2013-01-28 2 - for - 1
2007-06-25 2 - for - 1
2004-09-07 2 - for - 1
2002-03-08 2 - for - 1
2001-02-22 2 - for - 1

Will Gilead Sciences Inc Stock Split in 2024?

The answer will depend on the decisions of the company's managers and market volatility. Gilead Sciences Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when GILD stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Gilead Sciences Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.

Stock Splits of Industry Leaders

Ticker Symbol Latest Split Date Split Ratio
LLY 1997-10-16 2 - for - 1
NVO 2023-09-20 2 - for - 1
JNJ 2001-06-13 2 - for - 1
MRK 1999-02-17 2 - for - 1
NVS 2000-05-11 2 - for - 1
AMGN 1999-11-22 2 - for - 1
PFE 1999-07-01 3 - for - 1
BMY 1999-03-01 2 - for - 1
GILD 2013-01-28 2 - for - 1
GSK 2022-07-22 4 - for - 5
BIIB 2001-01-18 3 - for - 1
GRFS 2016-01-04 2 - for - 1
AMRN 2008-01-18 1 - for - 10
SCLX 2010-05-07 1 - for - 10
drug_manufacturers_general BMY
$57.53
price down icon 0.70%
drug_manufacturers_general SNY
$47.64
price down icon 0.22%
drug_manufacturers_general PFE
$24.84
price down icon 0.38%
$286.05
price down icon 0.09%
drug_manufacturers_general NVS
$103.35
price down icon 0.20%
drug_manufacturers_general MRK
$97.70
price up icon 1.40%
Cap:     |  Volume (24h):